Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated
Diabetes Archives
Print | Email | Share | Comments (0)

Drug Combo Slows Onset of Type 2 Diabetes


Aug 7, 2011

Type 2 Metformin and Rosiglitazone Combination

Low doses of metformin and rosiglitazone seem to delay the onset of type 2 in prediabetic people who have impaired glucose tolerance, according to a Canadian study. However, although the drug combination was effective over the first year of the study in helping to control glucose levels and insulin resistance, it was not effective subsequently in delaying the onset of insulin resistance and pancreatic beta cell deterioration.

The study at Mount Sinai Hospital in Toronto tracked 207 participants who had prediabetes. They were divided into two groups, one that received the metformin/rosiglitazone combination and another that received a placebo.

Metformin, one of the oldest, cheapest, and most effective drugs in the arsenal of diabetes medications, is often prescribed to people with prediabetes in an attempt to thwart the onset of type 2. It is often used in combination with other drugs to treat the actual disease.

Rosiglitazone, which belongs to the thiazolidinedione class of drugs, works by binding to receptors in fat cells and making them more receptive to insulin. In the U.S. market, GlaxoSmithKline sells it as a stand-alone drug, under the brand name Avandia, and in combination with metformin as Avandamet.   

The researchers concluded that while the drug combination delays the onset of type 2, it cannot prevent what seems to be an inevitable decline in beta cell functioning and insulin sensitivity over time.
(GlaxoSmithKline funded the study and provided the medications used in it. An abstract of the study is available online.)

 


Categories: Beta Cells, Diabetes, Diabetes, GlaxoSmithKline, Insulin, Metformin, Type 2 Issues, Type 2 Medications



You May Also Be Interested In...


Comments


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...


Username: Password:
Comment:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.